NOW: Fox News’ Lucas Tomlinson: “The Pentagon is taking this threat seriously. [The source] expects the lockdown to last for the next few hours. They have found some material, and they are testing that material. There are some rumors about what it is.”
“The largest office building in the world is on lockdown.”
“They’re going to test that material and we’re waiting on that test.”
🚨BREAKING: Over 200 Missiles Target Tehran as US Launches All-Out Attack
Reports indicate a major strike involving over 200 missiles hitting Tehran. Intelligence sources say the U.S. has vowed to completely destroy Iranian bases in an all-out assault.
President Trump is not holding back. The regime’s provocations have triggered a full response.
🚨 This whale just opened a $7.5 MILLION LONG on SpaceX.
Liquidation price: $90.44.
That's a 45% buffer.
This is conviction, not a gamble.
Someone is about to get smoked.
The IPO prices TONIGHT.
Tokenized securities just got more dynamic.
@ArchaxEx has launched real-time streaming cash flows on Hedera, enabling interest payments to update directly in investors' wallets on a near second-by-second basis using @USDC.
As tokenized securities are traded, payments automatically follow the asset. As ownership changes, cash flows continuously adjust. And because securities can be fractionalized, payments can be too.
This is another step toward more efficient capital markets.
https://t.co/a9DhA84Smw
Many are saying “the immune system is our last hope if we are going to cure cancer”.
So why has Chemo remained standard of care?
And why did Government agencies fail to develop “the most important molecule to cure cancer”?
https://t.co/06MoeElBb5
And in that same year (2007) IL-15 was identified, Dr. Wafik El-Deiry’s team discovered ONC201 (dordaviprone), a small molecule that recruits and activates NK cells into tumors.
Dr. Patrick Soon-Shiong unearthed the 2007 report live in front of NIH Director Dr. Jay Bhattacharya.
Dr. Patrick Soon-Shiong: “This is a report done in 2007.... every scientific thought leader had identified... the number 1 molecule... IL-15... the cytokine that stimulates the growth of T cells and NK cells... the thought leaders of the country have known for 20 years.”
The connection? NK cells.
El-Deiry’s ONC201 attracts and activates NK cells inside tumors, while Soon-Shiong’s therapy boosts their numbers and power body-wide.
Two complementary arms of the same innate immune strategy.
Prof. El Deiry: “We discovered a drug... it boosts our innate immune system.. the same type of Natural Killer Cells that Dr. Soon-Shion is trying to use to help patients.”
Yet the toxic chemotherapy paradigm still dominates.
Why the slow shift away from it?
$IBRX
ANKTIVA has achieved rapid U.S. market access, covering hundreds of millions of insured lives. ImmunityBio is accelerating adoption through a dual-track strategy targeting premier academic cancer centers and high-volume community urology practices
America’s biggest banks are reportedly building a tokenised deposit network.
Could $HBAR be in the conversation?
Nilmini Rubin @hedera's head of policy is says here they are already speaking with policymakers and big banks!
And they are all impressed by the hashgraph tech..
$IBRX
ALC rising after ANKTIVA treatment is exactly the kind of real-world signal bulls want to see.
This is not just a chart story anymore.
Patients are posting biological response, mild side effects, and renewed hope.
That is why the ANKTIVA story keeps getting harder to ignore.
Today, @hedera joined a coalition of over 200 organizations urging Senate leadership to bring the Clarity Act to the floor without delay.
The bill passed the Banking Committee with bipartisan backing and would establish clear rules for digital asset markets, strengthen consumer protections, and ensure American competitiveness.
It’s time for Clarity.
🧬 A Cancer Treatment That Activates Your Body’s “Killer Cells”
Dr. Patrick Soon-Shiong helped develop ANKTIVA, a new immunotherapy that activates the body’s natural killer (NK) cells and T-cells to fight cancer more effectively.
The treatment is now approved in the U.S. for certain bladder cancer patients and has also received approval in Saudi Arabia, giving hope for a new generation of immune-based cancer treatments.
Source
ImmunityBio. ANKTIVA® regulatory approvals and immunotherapy research
🚨Hedera hedera-hashgraph:native is the only crypto network that has been fully audited by Anthropic’s Claude Mythos as part of the Linux Foundation’s exclusive access to the world’s most powerful AI…
Definitely extremely relevant as today’s zCash incident shows.
Hedera’s security is AI-proof.
Please release #ANKTIVA for all cancers. Lori’s husband is evidence that it is working along with others that from the financial burden of cancer could not be there today. @POTUS@FDA_KyleD@SecKennedy Save Lives!!
Hedera just bought their biggest competitor...
A silent multi-million dollar acquisition went down behind closed doors, changing the blockchain landscape forever.
The Hadera Governing Council has purchased the intellectual property of its largest permissioned competitor, Hyperledger Fabric, from the Linux Foundation. This calculated structural chess move is designed to funnel the world's largest corporate supply chains, banks, and logistics networks onto a single public consensus service.
Within hours of the announcement, sophisticated trading algorithms responded instantly, triggering a sharp bounce off the eight and a half cent support level and sending futures volumes skyrocketing by 242%.
The corporate world loves blockchain technology but despises public ledgers where proprietary data is viewable by competitors.
For years, Hyperledger Fabric was the king of this hidden ecosystem, allowing massive syndicates to build private networks. However, these isolated networks lacked a public consensus mechanism. This new integration allows private networks to operate behind closed doors while periodically flushing a cryptographic hash of transaction histories to the public ledger.
Make sure to subscribe for more in depth crypto breakdowns as we track this transition from theoretical utility to absolute corporate capture.
#CryptoNews #HBAR #Hyperledger
$IBRX
Lori met with Senator Ron Johnson’s team and says he is well aware of ANKTIVA.
That is a big deal.
This is no longer just biotech Twitter talking to itself.
Patient access, FDA pressure, political awareness, and real-world demand are all building at the same time.